Schizophrenia is a challenging diagnosis both domestically and across the world. Various treatment guidelines have been developed by key thought leaders to share perspectives on acute and long-term management of Schizophrenia. Join Jehan Marino, Senior Medical Science Liaison for Otsuka Pharmaceutical Development and Commercialization, as she moderates a robust discussion with Dr. Christoph Correll. Dr. Correll will provide his perspectives of schizophrenia guidelines development, with a focus on key similarities and differences.

Register here.